Glaucoma: Overview
Open Angle Glaucoma: Treatment
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Glucose Transporters
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Angle Closure Glaucoma: Treatment
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 31, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
Auta Viviane Rocha1, Teddy Talbot, Thiago Magalhães da Silva
1Universidade Estadual de Santa Cruz, Departamento de Ciências da Saúde, Laboratório de Farmacogenômica e Epidemiologia Molecular, Ilhéus, Bahia, Brazil.
Glutathione S-transferase (GST) gene variations, particularly the GSTM1 null polymorphism, are linked to an increased risk of primary open angle glaucoma (POAG). These genetic factors also correlate with more severe disease characteristics in the Brazilian population.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: